TUCSON, Ariz., — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the commercial release and immediate availability of HTG EdgeSeq Reveal version 3.0, adding additional applications and software functionalities. The HTG EdgeSeq Reveal, launched in January 2019, is a web-based biostatistical analysis software suite […]
(ANN ARBOR, MICH.) Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits recently launched a new ACE2 Swift Normalase® Amplicon Panel (SNAP) to further research on the main functional receptor for viral entry of Coronavirus. With global numbers of COVID-19 cases increasing, Swift remains committed to providing tools to […]
Sydney, Australia – AXT are proud to announce that they have partnered with France-based Poietis to bring their next-generation bioprinting platforms to Australia. The NGB (Next Generation Bioprinting) system is a world first using laser-assisted bioprinting technology to print cells (from aggregates and cellular spots to single cell) rapidly and precisely in complex cellular formations in […]
A New SARS-CoV-2 Spike Protein Biosensor Chip was Successfully Deployed for Simultaneous Measurements of IgG, IgA, and IgM Using Only 2 µL of Serum per Patient SALT LAKE CITY, UTAH, USA – Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has announced the availability of a highly accurate assay for simultaneously measuring the concentration […]
Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib CARLSBAD, Calif. — Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui Medicine Co., Ltd. (JHM), to develop a CDx that will […]
aMoon leads round to expand product portfolio and advance commercial efforts for MOBILion’s SLIM technology for biotherapeutics characterization and novel biomarker discovery. Chadds Fords, PA. — MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, today announced a $35 million Series B funding round. The oversubscribed round was […]
Rotterdam, The Netherlands, VIROCLINICS-DDL is pleased to announce the signing of a new collaboration agreement with REPROCELL. REPROCELL will provide sample processing services to VIROCLINICS-DDL to support several clinical research projects. VIROCLINICS-DDL is the global leader in clinical trial management services, focused on viral targets such as influenza, COVID-19, RSV, HBV and Polio. REPROCELL will provide sample processing services in Japan to VIROCLINICS-DDL and will support […]
BRANFORD, Conn. — IsoPlexis, the leader in single-cell functional proteomics, today announced a partnership with the Division of Infectious Diseases, Department of Medicine at Columbia University, IsoPlexis’ Single-Cell Secretome immune profiling solutions will be used to study cellular drivers of durable and protective immune response to COVID-19. (PRNewsfoto/IsoPlexis) T cell and other immune cell polyfunctional cytokine responses on IsoPlexis’ platform have previously […]
CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research CELLINK, a leading provider of innovative biomaterials and technologies for 3D bioprinting applications in the life sciences, announced a collaboration with Carcinotech, which focuses on the production of cancer research models for drug testing, cancer drug discovery and the study of cancer […]
CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research CELLINK, a leading provider of innovative biomaterials and technologies for 3D bioprinting applications in the life sciences, announced a collaboration with Carcinotech, which focuses on the production of cancer research models for drug testing, cancer drug discovery and the study of cancer […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
